Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2011

Jan 31, 2011

29745_dirs_2011-01-31_ac7d6257-d3dc-4ba1-a3dc-b63a0eecba56.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-12-31

Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-03-22 Common Stock G 330 $0.00 Disposed 75410 Direct
2010-04-28 Common Stock G 175 $0.00 Disposed 75235 Direct
2010-05-03 Common Stock G 145 $0.00 Disposed 75090 Direct
2010-06-21 Common Stock G 1160 $0.00 Disposed 73930 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6082 Indirect